Primary Record
Agomelatine
- In stock
- 5,550 g
- Purity
- 99.5 %
- CAS
- 138112-76-2
Compound Identifiers & Properties
- CAS
- 138112-76-2
- PubChem CID
- 82148
- SMILES
- CC(=O)NCCC1=CC=CC2=C1C=C(C=C2)OC
- Canonical SMILES
- COc1ccc2cccc(CCNC(C)=O)c2c1
Names & Synonyms
- Agomelatine
- Thymanax
- Valdoxan
- 138112-76-2
- Melitor
- Agomelatina
- Agomelatine-d4
- Agomelatine [INN]
- acetamide
- agomelatinum
- Agomelatine/
- Agomelatine-d6
- Valdoxan (TN)
- Agomelatine(INN)
- N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
- Agomelatine (INN)
- N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide
- AGO-178
- Agomelatine [INN:BAN]
- Agomelatine (Standard)
- AGOMELATINE 1G
- AGO178
- AGO 178
- S20098
- AGOMELATINE [MI]
- C15H17NO2
- RefChem:110192
- AGO178C
- S-20098
- DTXSID3057642
- MFCD00916659
- CHEMBL10878
- D0Y8UB
- UNII-137R1N49AD
- AC1L32UM
- 137R1N49AD
- AGOMELATINE [MART.]
- AGOMELATINE [WHO-DD]
- DTXCID4031431
- GTPL198
- cc-323
- MLS006011913
- SCHEMBL114476
- AGOMELATINE [EMA EPAR]
- N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide
- YJYPHIXNFHFHND-UHFFFAOYSA-N
- orb1308595
- ZINC5608
- S 20098
- Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- Agomelatine - Bio-X trade mark
- SCHEMBL27844916
- SCHEMBL29930659
- Agomelatine, >=98% (HPLC)
- CTK8B4489
- AOB4719
- N06AX22
- CHEBI:134990
- BCPP000421
- GLXC-03028
- HMS3604N09
- HMS3648G18
- HMS3654B07
- HMS3753C13
- HMS3884A07
- HMS5079G21
- N-(2-(7-Methoxynaphth-1-yl)ethyl)acetamide
- N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide
- BCP02084
- CID82148
- ETB38944
- MSK10883
- Tox21_113772
- ABP000593
- ANW-45263
- BBL029084
- BDBM50035179
- C15-H17-N-O2
- CA0119
- CID:82148
- EBC-11261
- HY-17038R
- NCGC00253646-01
- NP3699
- PDSP1_001305
- PDSP1_001784
- PDSP2_001289
- PDSP2_001767
- s1243
- STL237728
- N-(2-(7-Methoxy-1-naphthalenyl)ethyl)acetamide
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide
- AKOS005145681
- AC-3395
- ACN-032365
- AN-3547
- BCP9000250
- CCG-221950
- CS-0740
- CS-O-10192
- DB06594
- FA17244
- KS-1247
- LS-9830
- RL01671
- RTC-070882
- SB19508
- KS-00000V37
- NCGC00253646-10
- Valdoxan, Melitor, Thymanax, Agomelatine
- 4CA-0129
- AJ-08251
- AK-48819
- BA167079
- BC681920
- HY-17038
- N-[2-(7-Methoxynaphth-1-Yl)Ethyl]Acetamide
- S035
- SC-20244
- SID:53789947
- SMR002530056
- SY053050
- AB0005091
- AB2000727
- J481.046E
- ST2419642
- TC-070882
- A2606
- AM20090763
- B2262
- CAS-138112-76-2
- FT-0657383
- NS00007664
- SW219177-1
- A10048
- A19445
- Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-
- D02578
- M-1683
- N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide
- Valdoxan, Melitor, Thymanax, 138112-76-2
- ~{N}-[2-(7-methoxynaphthalen-1-yl)ethyl]ethanamide
- AB01274769-01
- AB01274769_02
- Agomelatine =98.0% (by HPLC, total nitrogen)
- EN300-7405421
- 112A762
- 2-AMINO-4-(TRIFLUOROMETHYL)BENZONITRI 5G
- C084711
- L000528
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide
- Q395229
- SR-01000944938
- Acetamide,N-[2-(7-methoxy-1-naphthalenyl)ethyl]-
- I14-1072
- SR-01000944938-1
- SR-01000944938-3
- BRD-K84698278-001-03-4
- F0001-2383
- 1079389-44-8
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide; S-20098
- (4-Chlorophenyl)-[(9H-fluoren-9-ylmethoxycarbonylamino)]-aceticacid
- N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide(Agomelatine)
- 2-Amino-4-(trifluoromethyl)benzonitrile =98.0% (by GC, total nitrogen)
- Agomelatine, 99%, a competitive antagonist of (5-HT2C) receptors - 1G 1g
- N-[1,1,2,2-tetradeuterio-2-(7-methoxynaphthalen-1-yl)ethyl]acetamide
- 1079389-42-6
- 1176316-99-6
- AWY
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide; AGO 178; Agomelatine; N-[2-(7-Methoxy-1-naphthyl)ethyl]acetamide; N-[2-(7-Methoxynaphthalen-1-yl)ethyl]acetamide; S 20098; Valdoxan
- N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide; N-[2-(7-Methoxy-1-naphthyl) ethyl]acetamide; S20098; Valdoxan; N-(2-(7-methoxynaphthalen-1-yl)ethyl)acetamide